Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI, 48202, USA.
Heart Fail Rev. 2014 Jan;19(1):1-13. doi: 10.1007/s10741-013-9387-6.
The incidence of heart failure (HF) and diabetes mellitus is rapidly increasing and is associated with poor prognosis. In spite of the advances in therapy, HF remains a major health problem with high morbidity and mortality. When HF and diabetes coexist, clinical outcomes are significantly worse. The relationship between these two conditions has been studied in various experimental models. However, the mechanisms for this interrelationship are complex, incompletely understood, and have become a matter of considerable clinical and research interest. There are only few animal models that manifest both HF and diabetes. However, the translation of results from these models to human disease is limited, and new models are needed to expand our current understanding of this clinical interaction. In this review, we discuss mechanisms of insulin signaling and insulin resistance, the clinical association between insulin resistance and HF, and its proposed pathophysiologic mechanisms. Finally, we discuss available animal models of insulin resistance and HF and propose requirements for future new models.
心力衰竭(HF)和糖尿病的发病率迅速增加,并与预后不良相关。尽管治疗取得了进展,但 HF 仍然是一个主要的健康问题,具有高发病率和死亡率。当 HF 和糖尿病同时存在时,临床结局明显恶化。这两种情况之间的关系在各种实验模型中进行了研究。然而,这种相互关系的机制很复杂,尚未完全了解,已成为相当多的临床和研究关注的问题。只有少数动物模型同时表现出 HF 和糖尿病。然而,将这些模型的结果转化为人类疾病是有限的,需要新的模型来扩展我们对这种临床相互作用的现有理解。在这篇综述中,我们讨论了胰岛素信号和胰岛素抵抗的机制、胰岛素抵抗与 HF 之间的临床关联及其提出的病理生理机制。最后,我们讨论了现有的胰岛素抵抗和 HF 动物模型,并提出了对未来新型模型的要求。